Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issue
18-3
Table of Contents
Editors Selection
Glaucoma Dialogue
Glaucoma Opinion
Abstracts
Abstracts
Abstracted Journals
Classification List
Index of Authors
Search
Home
Abstracts
Index of Authors
Author #29667
advertisement
Park KH
32
Showing records 1 to 25 |
Display all abstracts from
Park KH
71526
Enhanced Ocular Efficacy of Topically-delivered Dorzolamide with Nanostructured Mucoadhesive Microparticles
Park CG
International Journal of Pharmaceutics
2017; 522: 66-73
71301
Relationship between Plasma Homocysteine Level and Glaucomatous Retinal Nerve Fiber Layer Defect
Lee JY
Current Eye Research
2017; 0: 1-6
71115
Vision-related Quality of Life in Korean Glaucoma Patients
Sung KR
Journal of Glaucoma
2017; 26: 159-165
71118
Inferior Macular Damage in Glaucoma: Its Relationship to Retinal Nerve Fiber Layer Defect in Macular Vulnerability Zone
Kim YK
Journal of Glaucoma
2017; 26: 126-132
71578
Efficacy and Tolerability of Travoprost 0.004%/Timolol 0.5% Fixed-Dose Combination for the Treatment of Primary Open-Angle Glaucoma or Ocular Hypertension Inadequately Controlled with Beta-Blocker Monotherapy
Lerner SF
Journal of Ophthalmology
2017; 2017: 1917570
71118
Inferior Macular Damage in Glaucoma: Its Relationship to Retinal Nerve Fiber Layer Defect in Macular Vulnerability Zone
Jeoung JW
Journal of Glaucoma
2017; 26: 126-132
71115
Vision-related Quality of Life in Korean Glaucoma Patients
Chun YS
Journal of Glaucoma
2017; 26: 159-165
71526
Enhanced Ocular Efficacy of Topically-delivered Dorzolamide with Nanostructured Mucoadhesive Microparticles
Kim YK
International Journal of Pharmaceutics
2017; 522: 66-73
71301
Relationship between Plasma Homocysteine Level and Glaucomatous Retinal Nerve Fiber Layer Defect
Kim JM
Current Eye Research
2017; 0: 1-6
71578
Efficacy and Tolerability of Travoprost 0.004%/Timolol 0.5% Fixed-Dose Combination for the Treatment of Primary Open-Angle Glaucoma or Ocular Hypertension Inadequately Controlled with Beta-Blocker Monotherapy
Park KH
Journal of Ophthalmology
2017; 2017: 1917570
71115
Vision-related Quality of Life in Korean Glaucoma Patients
Park CK
Journal of Glaucoma
2017; 26: 159-165
71301
Relationship between Plasma Homocysteine Level and Glaucomatous Retinal Nerve Fiber Layer Defect
Kim IT
Current Eye Research
2017; 0: 1-6
71578
Efficacy and Tolerability of Travoprost 0.004%/Timolol 0.5% Fixed-Dose Combination for the Treatment of Primary Open-Angle Glaucoma or Ocular Hypertension Inadequately Controlled with Beta-Blocker Monotherapy
Hubatsch DA
Journal of Ophthalmology
2017; 2017: 1917570
71526
Enhanced Ocular Efficacy of Topically-delivered Dorzolamide with Nanostructured Mucoadhesive Microparticles
Kim SN
International Journal of Pharmaceutics
2017; 522: 66-73
71118
Inferior Macular Damage in Glaucoma: Its Relationship to Retinal Nerve Fiber Layer Defect in Macular Vulnerability Zone
Park KH
Journal of Glaucoma
2017; 26: 126-132
71578
Efficacy and Tolerability of Travoprost 0.004%/Timolol 0.5% Fixed-Dose Combination for the Treatment of Primary Open-Angle Glaucoma or Ocular Hypertension Inadequately Controlled with Beta-Blocker Monotherapy
Erichev V
Journal of Ophthalmology
2017; 2017: 1917570
71526
Enhanced Ocular Efficacy of Topically-delivered Dorzolamide with Nanostructured Mucoadhesive Microparticles
Lee SH
International Journal of Pharmaceutics
2017; 522: 66-73
71115
Vision-related Quality of Life in Korean Glaucoma Patients
Kim HK
Journal of Glaucoma
2017; 26: 159-165
71301
Relationship between Plasma Homocysteine Level and Glaucomatous Retinal Nerve Fiber Layer Defect
Yoo CK
Current Eye Research
2017; 0: 1-6
71526
Enhanced Ocular Efficacy of Topically-delivered Dorzolamide with Nanostructured Mucoadhesive Microparticles
Huh BK
International Journal of Pharmaceutics
2017; 522: 66-73
71301
Relationship between Plasma Homocysteine Level and Glaucomatous Retinal Nerve Fiber Layer Defect
Won YS
Current Eye Research
2017; 0: 1-6
71578
Efficacy and Tolerability of Travoprost 0.004%/Timolol 0.5% Fixed-Dose Combination for the Treatment of Primary Open-Angle Glaucoma or Ocular Hypertension Inadequately Controlled with Beta-Blocker Monotherapy
Paczka JA
Journal of Ophthalmology
2017; 2017: 1917570
71115
Vision-related Quality of Life in Korean Glaucoma Patients
Yoo C; Kim YY
Journal of Glaucoma
2017; 26: 159-165
71301
Relationship between Plasma Homocysteine Level and Glaucomatous Retinal Nerve Fiber Layer Defect
Kim JH
Current Eye Research
2017; 0: 1-6
71578
Efficacy and Tolerability of Travoprost 0.004%/Timolol 0.5% Fixed-Dose Combination for the Treatment of Primary Open-Angle Glaucoma or Ocular Hypertension Inadequately Controlled with Beta-Blocker Monotherapy
Roberts TV
Journal of Ophthalmology
2017; 2017: 1917570
«
1
2
»
Issue
18-3
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
24-1 (2024)
23-4 (2023)
23-3 (2023)
23-2 (2023)
23-1 (2022)
22-4 (2022)
22-3 (2022)
22-2 (2021)
22-1 (2021)
21-4 (2021)
21-3 (2021)
21-2 (2021)
21-1 (2020)
20-4 (2020)
20-3 (2020)
20-2 (2019)
20-1 (2019)
19-4 (2019)
19-3 (2018)
19-2 (2018)
19-1 (2018)
18-4 (2017)
18-3 (2017)
18-2 (2017)
18-1 (2017)
17-4 (2016)
17-3 (2016)
17-2 (2016)
17-1 (2016)
16-4 (2015)
16-3 (2015)
16-2 (2015)
16-1 (2014)
15-4 (2014)
15-3 (2014)
15-2 (2013)
15-1 (2013)
14-4 (2013)
14-3 (2013)
14-2 (2013)
14-1 (2012)
13-4 (2012)
13-3 (2011)
13-2 (2011)
13-1 (2011)
12-4 (2011)
12-3 (2010)
12-2 (2010)
12-1 (2010)
11-4 (2010)
11-3 (2009)
11-2 (2009)
11-1 (2009)
10-4 (2009)
10-3 (2008)
10-2 (2008)
10-1 (2008)
9-4 (2008)
9-3 (2007)
9-2 (2007)
9-1 (2007)
8-4 (2007)
8-3 (2006)
8-2 (2006)
8-1 (2006)
7-3 (2006)
7-2 (2005)
7-1 (2005)
6-3 (2005)
6-2 (2004)
6-1 (2004)
5-3 (2004)
5-2 (2003)
5-1 (2003)
4-3 (2003)
4-2 (2002)
4-1 (2002)
3-3 (2002)
3-2 (2001)
3-1 (2001)
2-3 (2001)
2-2 (2000)
2-1 (2000)
1-3 (2000)
1-2 (1999)
1-1 (1999)
advertisement